One of the illnesses brought on by hematopoietic system disorders is blood disorder diseases (BDDs). Individuals suffering from hematological disorders frequently confront major challenges in terms of prognosis and quality of life. While numerous therapy methods, such as targeted therapies, immunotherapies, and gene therapies, have emerged as potential treatments, there is an urgent need to thoroughly assess their effectiveness and patient consequences.
Reference:
Wei, M. Y. (2019, November 28). Nanomedicines: A potential treatment for blood disorder diseases. Frontiers. https://www.frontiersin.org/articles/10.3389/fbioe.2019.00369/full
The use of gene, immuno, and targeted therapies, which have improved patient prognoses and quality of life, has led to substantial advancements in treating hematological diseases. However, issues still need to be resolved, including the high cost of present treatments, potential long-term side effects, etc.
With continuous research to improve these treatments and expand the range of hematological disorders to which they are applicable, chances for improving patients' lives with these conditions are even more promising. The ongoing fight against hematological diseases aims to strike a balance between effective treatment and retaining an optimal quality of life.
- Badges
- Science topic
- Similar topics
- Computer Science
- Program